Member login

E-mail address:

Password:
Remember me

WORLD COURIER ANNOUNCES SUBSTANTIAL EXPANSION TO EXISTING GROUND EUROPE FLEET

London (Jan 13, 2014) – World Courier, an AmerisourceBergen (NYSE: ABC) company, today announces the upcoming expansion of the World Courier Ground Europe (WCGE)fleet.
More info >>

Case Study: Cmed’s Mobile Data Management Solution

Cmed Clinical Services

The trial presented to Cmed was a randomized, double blinded, placebo and active controlled study to evaluate the cardiac safety of multiple doses of [study drug] in health volunteers. The pharmaceutical company, who were into the second year of development of a potential blockbuster compound for the treatment of chronic myelogenous leukaemia (CML), were requested by the FDA to design a trial to provide information on the cardiac safety of different dose levels of the study drug in healthy adult volunteers. The primary objective of the study was specifically to find the maximum tolerated dose before QTc levels became unsafe. All development of the compound was put on hold until the results of this study were submitted to the FDA and approval granted for the compound to progress into full development.
More info >>

Controlled Release

12-13 March 2014, Holiday Inn Regents Park, London, UK

SMi is proud to present its 11th annual Controlled Release conference, held in central London on the 12 & 13 March 2014. The meeting will continue in a long tradition of critically acclaimed speakers who are pioneers in their field.
More info >>